Literature DB >> 1569161

Aluminum metabolism and bone histology after kidney transplantation: a one-year follow-up study.

K P Nordal1, E Dahl, J Halse, L Aksnes, Y Thomassen, A Flatmark.   

Abstract

Parathyroid activity, bone aluminum (Al) metabolism, bone histology, and clinical bone disease were studied in 55 successfully grafted kidney recipients at transplantation (Tx) and after 1 yr of immunosuppression with a low dose corticosteroid and a high dose cyclosporin-A regimen. Symptoms of Al-related bone disease disappeared after Tx. Serum Al and stainable bone Al decreased. The rate of Al removal from the bone surfaces was independent of graft function (creatinine range, 62-415 mumol/L) and bone turnover. Osteoblast activity and bone formation rate increased, while mineralization lag time normalized. Indices of bone resorption remained elevated, indicating persisting hyperparathyroidism. Eighteen percent of the recipients had posttransplant hypercalcemia, most likely caused by incomplete involution of hyperplastic parathyroid glands, while 53% had normocalcemic hyperparathyroidism related to impaired graft function. Cortical thickness decreased, while cancellous bone volume remained stable after Tx; both indices correlated significantly at follow-up with their respective values at Tx. None of 46 radiologically examined recipients had aseptic bone necrosis 1 yr after Tx.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569161     DOI: 10.1210/jcem.74.5.1569161

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  2 in total

1.  FGF23 and mineral metabolism in the early post-renal transplantation period.

Authors:  Katherine Wesseling-Perry; Renata C Pereira; Eileen Tsai; Robert Ettenger; Harald Jüppner; Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2013-07-15       Impact factor: 3.714

Review 2.  Drug-vitamin D interactions: a systematic review of the literature.

Authors:  Kim Robien; Sarah J Oppeneer; Julia A Kelly; Jill M Hamilton-Reeves
Journal:  Nutr Clin Pract       Date:  2013-01-10       Impact factor: 3.080

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.